Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wang

Showing results (541-550 of 603) with videos related to

Pageof 61
Sort By:
British Journal of Haematology|September 7, 2022
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplantHua-Jay J Cherng, Guofan Xu, Lei Feng, et al.
The New England Journal of Medicine|February 6, 2020
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid TumorsEnli Liu, David Marin, Pinaki Banerjee, et al.
Science Signaling|February 18, 2016
ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignanciesJo Ishizawa, Kensuke Kojima, Dhruv Chachad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 StudyMichael Wang, Javier Munoz, Andre Goy, et al.
World Neurosurgery|May 6, 2018
Loss of Local Tumor Control After Index Surgery for Spinal Metastases: A Prospective Cohort StudyBart Depreitere, Federico Ricciardi, Mark Arts, et al.
Nature Communications|April 19, 2017
Unification of de novo and acquired ibrutinib resistance in mantle cell lymphomaXiaohong Zhao, Tint Lwin, Ariosto Silva, et al.
Frontiers in Immunology|February 17, 2025
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomasGohar S Manzar, Chelsea C Pinnix, Stephanie O Dudzinski, et al.
Blood|May 5, 2012
An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myelomaRavi Vij, Michael Wang, Jonathan L Kaufman, et al.
British Journal of Haematology|June 20, 2014
Double hit lymphoma: the MD Anderson Cancer Center clinical experienceYasuhiro Oki, Mansoor Noorani, Pei Lin, et al.
Cancer Letters|December 3, 2014
Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancerChuncheng Hao, Li Wang, Shaohua Peng, et al.
Pageof 61

Showing results (541-550 of 603) with videos related to

Sort By:
Pageof 61
British Journal of Haematology|September 7, 2022
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplantHua-Jay J Cherng, Guofan Xu, Lei Feng, et al.
The New England Journal of Medicine|February 6, 2020
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid TumorsEnli Liu, David Marin, Pinaki Banerjee, et al.
Science Signaling|February 18, 2016
ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignanciesJo Ishizawa, Kensuke Kojima, Dhruv Chachad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 StudyMichael Wang, Javier Munoz, Andre Goy, et al.
World Neurosurgery|May 6, 2018
Loss of Local Tumor Control After Index Surgery for Spinal Metastases: A Prospective Cohort StudyBart Depreitere, Federico Ricciardi, Mark Arts, et al.
Nature Communications|April 19, 2017
Unification of de novo and acquired ibrutinib resistance in mantle cell lymphomaXiaohong Zhao, Tint Lwin, Ariosto Silva, et al.
Frontiers in Immunology|February 17, 2025
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomasGohar S Manzar, Chelsea C Pinnix, Stephanie O Dudzinski, et al.
Blood|May 5, 2012
An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myelomaRavi Vij, Michael Wang, Jonathan L Kaufman, et al.
British Journal of Haematology|June 20, 2014
Double hit lymphoma: the MD Anderson Cancer Center clinical experienceYasuhiro Oki, Mansoor Noorani, Pei Lin, et al.
Cancer Letters|December 3, 2014
Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancerChuncheng Hao, Li Wang, Shaohua Peng, et al.
Pageof 61